The latest medical news on Clinical Pharmacology

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about clinical pharmacology gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
Pharma Forum

TRACON Pharmaceuticals' president and CEO Charles Theuer on changes in oncology and cancer trials, and how his firm is keeping pace

Pharma Forum

The US FDA has granted a priority review to Johnson & Johnson’s Invokana in diabetic kidney disease, signposting

Pharma Forum

MYRX365, a technology-based pharmacy company, has bought RealTime Clinic to gain access to its set of digital patient management tools.

Pharma Forum

How are you mapping your digital KOLs?

Pharma Times

The newly developed ‘ARK’ will develop a programme of events to facilitate networking in AI research across King’s.

Pharma Forum

2 weeks until SMi’s Pharma Microbiology West Coast

Pharma Times

The approval of the drug is a new way of treating adults with TRD that is unlike other treatment options in psychiatry.

Pharma Forum

Santhera has announced it is licensing its LHON drug Raxone (idebenone) to Chiesi Group for an upfront payment of €44 million..

Pharma Times

Too many children are being admitted to secure hospitals unnecessarily, and in some cases are spending months and years of their childhood in insti...

Pharma Forum

Novartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company leaders give an overvie...

Pharma Times

SCIB2 is to be administered using a new nanoparticle formulation in a planned Phase I/II clinical trial.

Pharma Times

Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug p...